These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. How invariant natural killer T cells respond to infection by recognizing microbial or endogenous lipid antigens. Brigl M; Brenner MB Semin Immunol; 2010 Apr; 22(2):79-86. PubMed ID: 19948416 [TBL] [Abstract][Full Text] [Related]
67. Leukoreduction system chambers are an efficient, valid, and economic source of functional monocyte-derived dendritic cells and lymphocytes. Pfeiffer IA; Zinser E; Strasser E; Stein MF; Dörrie J; Schaft N; Steinkasserer A; Knippertz I Immunobiology; 2013 Nov; 218(11):1392-401. PubMed ID: 23932569 [TBL] [Abstract][Full Text] [Related]
68. Natural variations at position 93 of the invariant Vα24-Jα18 α chain of human iNKT-cell TCRs strongly impact on CD1d binding. Sanderson JP; Waldburger-Hauri K; Garzón D; Matulis G; Mansour S; Pumphrey NJ; Lissin N; Villiger PM; Jakobsen B; Faraldo-Gómez JD; Gadola SD Eur J Immunol; 2012 Jan; 42(1):248-55. PubMed ID: 21956730 [TBL] [Abstract][Full Text] [Related]
69. CD1d-restricted NKT cells modulate placental and uterine leukocyte populations during chlamydial infection in mice. Habbeddine M; Verbeke P; Delarbre C; Moutier R; Prieto S; Ojcius DM; Kanellopoulos-Langevin C Microbes Infect; 2013 Nov; 15(13):928-38. PubMed ID: 23999314 [TBL] [Abstract][Full Text] [Related]
70. Immunometabolic Activation of Invariant Natural Killer T Cells. Ververs FA; Kalkhoven E; Van't Land B; Boes M; Schipper HS Front Immunol; 2018; 9():1192. PubMed ID: 29892305 [TBL] [Abstract][Full Text] [Related]
71. Temporal effects of 3 commonly used anticoagulants on hematologic and biochemical variables in blood samples from macaws and Burmese pythons. Harr KE; Raskin RE; Heard DJ Vet Clin Pathol; 2005 Dec; 34(4):383-8. PubMed ID: 16270264 [TBL] [Abstract][Full Text] [Related]
72. CD1d-restricted antigen presentation by Vγ9Vδ2-T cells requires trogocytosis. Schneiders FL; Prodöhl J; Ruben JM; O'Toole T; Scheper RJ; Bonneville M; Scotet E; Verheul HM; de Gruijl TD; van der Vliet HJ Cancer Immunol Res; 2014 Aug; 2(8):732-40. PubMed ID: 24934445 [TBL] [Abstract][Full Text] [Related]
73. A simple method for separation of buffy coat from peripheral blood of chickens. Sengar DP; Jerome FN; Douglas RJ Can J Comp Med; 1968 Oct; 32(4):593-7. PubMed ID: 4234792 [TBL] [Abstract][Full Text] [Related]
74. Cross-talk between iNKT cells and monocytes triggers an atheroprotective immune response in SLE patients with asymptomatic plaque. Smith E; Croca S; Waddington KE; Sofat R; Griffin M; Nicolaides A; Isenberg DA; Torra IP; Rahman A; Jury EC Sci Immunol; 2016 Dec; 1(6):. PubMed ID: 28783690 [TBL] [Abstract][Full Text] [Related]
75. Storage of buffy coat preparations at 22 degrees C in plastic containers with different gas permeability. Eriksson L; Eriksson G; Högman CF Vox Sang; 1997; 73(2):74-80. PubMed ID: 9304775 [TBL] [Abstract][Full Text] [Related]
79. License to Kill: When iNKT Cells Are Granted the Use of Lethal Cytotoxicity. Díaz-Basabe A; Strati F; Facciotti F Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486268 [TBL] [Abstract][Full Text] [Related]